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Abstract
Introduction: Mucinous adenocarcinoma is a rare neoplasm of the gastrointestinal tract and one of the three major 
histological subtypes of the primary appendiceal adenocarcinoma. The most common type of presentation is that of 
acute appendicitis and the diagnosis is usually occurred after appendectomy. The accurate preoperative diagnosis and 
management of the above condition represents a real challenge when uncommon anatomic anomalies such intestinal 
malrotation and situs inversus take place. Situs inversus totalis with an incidence of 0.01% is an uncommon condition 
caused by a single autosomal recessive gene of incomplete penetration in which the major visceral organs are 
mirrored from their normal positions.
Case presentation: We present an unusual case of a 59 years old, previously healthy man presented with a left lower 
quadrant abdominal pain, accompanied with low fever, leukocytosis, anorexia and constipation. A chest radiograph 
demonstrated dextrocardia with a right side positioned stomach bubble. Both preoperative US and CT scan of the 
abdomen and pelvis declared situs inversus, with a characteristic thickening in its wall, appendix situated in the left 
lower quadrant of the abdomen. These findings reached to the diagnosis of acute appendicitis with situs inversus and 
a standard appendicectomy was performed. Pathologic evaluation established primary mucinous adenocarcinoma of 
the appendix and three months afterwards the patient underwent a subsequent extended left hemicolectomy.
Conclusion: In conclusion, the occurrence of primary appendiceal mucinous adenocarcinoma along with situs 
inversus, definitely accounts as a unique clinical case. Even synchronous manifestation of primary mucinous 
adenocarcinoma of the appendix and situs inversus totalis represents an unusual anatomo-pathological entity, all 
physicians should be familiar having the knowledge to make an appropriate and accurate diagnosis that will lead to 
prompt and correct treatment.
Introduction
Appendiceal carcinomas represent a relatively uncom-
mon clinical entity. A recently published population-
based study, concentrated in the period 1973-1998, from
The National Cancer Institute's (NCI) Surveillance, Epi-
demiology, and End Results (SEER) program concluded
that the age-adjusted incidence of appendiceal malignan-
cies is approximately 0.12 cases per 1,000,000 people per
year. The same study suggested the mucinous adenocar-
cinoma as the most frequent histologic type among the
appendiceal identified carcinomas, while carcinoid was
the second most frequent histologic diagnosis [1].
Mucinous adenocarcinoma represents an uncommon
neoplasm of the gastrointestinal tract and one of the
three major histological subtypes of the primary appen-
diceal adenocarcinoma [1,2] occupying only 0.01-0.2% [3]
(while in some others reports the percentage reaches 0.4
to 1%) [3] of all gastrointestinal neoplasms. Appendiceal
carcinomas are infrequently suspected preoperatively
and, not as much of than 50% of cases are diagnosed dur-
ing intraoperative exploration of the peritoneal cavity [4].
Diagnosis of mucinous adenocarcinoma of the appendix
usually occurs after appendectomy or other explorative
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Page 2 of 5surgical procedures (appendiceal adenocarcinomas are
noted to have a propensity for early perforation and peri-
appendiceal abscesses) and consequent pathologic evalu-
ation of the appendiceal specimen [3,5].
The formal right hemicolectomy is considered as the
recommended treatment for all patients with nonmeta-
static adenocarcinoma of the appendix. Though muci-
nous' adenocarcinoma spread to adjacent organs is
detectable at presentation in a percentage 63%, the
approximate overall 5-year survival rate at about 20.5%,
arising to 55-60% after right hemicolectomy for nonmet-
astatic disease (widespread metastases are present in 10-
50% [6] of the patients with appendiceal adenocarci-
noma) and varying with stage and grade [5,6]. The use of
appendicectomy alone in should be restricted for cases of
adenocarcinoids limited to a small area of the appendix.
To be more detailed, right hemicolectomy is considered
to be the treatment of choice for all lesions with invasion
beyond the mucosa, and, appendicectomy alone seems to
be the ideal treatment for in situ and localised cases. This
therapeutical option was supported by Varisco et al [7],
on their meta-analysis (involving 100 patients), regarding
the necessity of hemicolectomy in appendiceal carcinoma
malignancies, with low tumour histology and no caecal
involvement. As for mucinous appendiceal tumours with
involvement of the appendiceal or distal ileocolic lymph
nodes and documented peritoneal seeding or inadequate
resection margin, authors suggest that there is no survival
advantage in performing a right hemicolectomy alone [8],
and, the application of intraperitoneal chemotherapy, in
addition to the right hemicolectomy is recommended [9-
14]. Aiming to be more precise, the current and recom-
mended surgical/oncological management for patients
diagnosed with peritoneal metastasis or peritoneal carci-
nomatosis, is consisted of the combined utilize of cytore-
ductive surgery and intraoperative/intra-abdominal
chemotherapy [9-14]. The surgical procedure is directed
to the visible disease removal throughout a thorough
peritonectomy and visceral resections when is indicated.
In order to avoid entrapment of tumour cells at operative
sites and to destroy small residual mucinous tumour nod-
ules, cytoreductive surgery is combined with intraperito-
neal chemotherapy or to be more accurate
intraperitoneal hyperthermic chemoperfusion. The lat-
ter includes 5-fluoro-2'-deoxyuridine (FUDR) plus leuco-
vorin (LV) [15], 1000 mg/m2 and 240 mg/m2 respectively,
either 200 mg/M2 of oxaliplatin for a 2-h chemoperfusion
[16], or combination of mytomicin-C (MMC) with either
cisplatin [17] or fluorouracil [18]. Particularly intraperito-
neal chemotherapy with mitomycin at 42 degrees C is a
well tested chemotherapeutic agent. Fluorouracil is then
given postoperatively for 5 days. If the mucinous neo-
plasm is minimally invasive and cytoreduction complete,
these treatments result in a 20-year survival of 70% [14].
In the absence of a phase III study, this new combined
treatment should be regarded as the standard of care for
epithelial appendiceal malignant neoplasms and
pseudomyxoma peritonei syndrome [14].
The rareness of the disease makes any therapeutic com-
prehensive investigation to seem mistrustful. Based on
this motivation, formal studies have not been realised,
and no evidence of a possible advantage of systemic che-
motherapy for appendiceal adenocarcinoma exists. Based
on the similarities between this type of appendix cancer
and colon cancer, the treatment with systemic chemo-
therapy that is commonly used to treat colon cancer is
also often used for the "colonic-type" appendiceal cancer.
Some of the most commonly used intravenous chemo-
therapy agents consist of 5-FU, Leucovorin, Oxaliplatin
and Irinotecan [9].
Avastin, a monoclonal antibody displaying an anti-
angiogenic action, as well as bevacizumab are also some-
times added [19-21].
The location of the appendix in the left lower quadrant
is extremely rare. Left-sided acute appendicitis and peri-
appendiceal abscesses occur in association with two types
of congenital anomaly: intestinal malrotation and situs
inversus. Situs inversus totalis is an uncommon congeni-
tal anatomic abnormality in which the major visceral
organs are reversed or mirrored from their normal posi-
tions. The above congenital condition affects all major
structures within the thorax and the abdomen. Generally,
the organs are simply transposed through the sagittal
plane. The heart is located on the right side of the thorax,
the stomach and spleen on the right side of the abdomen,
while the liver and gall bladder on the left side. The left
lung is trilobed, while the right lung bilobed, and more-
over blood vessels, nerves, lymphatics and the intestines
are also transposed. If the heart is swapped to the right
side of the thorax, it is known as situs inversus with dex-
trocardia or situs inversus totalis [2,3].
This anatomic developmental anomaly totally differen-
tiates our standard clinical differential diagnoses and
complicates diagnosis of common intraperitoneal disease
processes such as biliary colic, acute appendicitis and
diverticulitis and the therapeutic management is often
delayed as a result of the incompatible clinical finding [2-
4].
It must be emphasized that up to 35% of the patients
with appendiceal adenocarcinoma to have a second GI
malignancy [6] that underlines the significant risk for
both synchronous and metachronous neoplasms [1,22].
Petrou et al. World Journal of Surgical Oncology 2010, 8:49
http://www.wjso.com/content/8/1/49
Page 3 of 5Such information is considered significant for the correct
evaluation, diagnosis and management that will lead to
the optimal surgical and oncological treatment.
Typically, patients with situs inversus have a normal life
expectancy while the great majority of persons with situs
inversus totalis are unconscious of their unusual anatomy,
until they seek medical attention with plain chest erect
film or ultrasonography for unrelated condition. Only in
rare cases of situs inversus totalis with cardiac anomalies
or for individuals with Kartagener syndrome and severe
bronchiectasis, life expectancy is reduced, but always
depended of the severity of the defect and the treatment
efficiency [3,6,23].
Case presentation
A 59 years old, previously healthy man, presented at the
emergency room of First Dept. of Surgery, Athens Medi-
cal School, LAIKON GENERAL HOSPITAL, with a left
lower quadrant abdominal pain, that arisen 24 h ago in
the umbilical area, accompanied with low fever, as well as
anorexia and constipation. Physical examination showed
the patient to be febrile (body temperature of 38.4) with a
mild suffering secondary to point tenderness on palpa-
tion of his left lower quadrant. Left-sided "Rebound" and
"McBurney's" signs were also noted. Laboratory tests
showed mild leukocytosis (11.6 × 109/L), accompanied
with moderate polymorphonuclear predominance (89%)
and an elevated CRP concentration (1 mg 55/L) and nor-
mal blood biochemistry analysis.
A standard preoperative chest radiograph demon-
strated dextrocardia, with the stomach bubble situated on
the right as well. Therewithal both Ultrasound (US) and
Computed tomography (CT) abdominal scanning
revealed situs inversus, with the appendix in the left
lower quadrant of the abdomen, with remarkable thick-
ening in its wall. It should be underlined that until then
the patient had been unsuspicious of having situs inver-
sus. These findings reached to the diagnosis of acute
appendicitis with situs inversus and a standard appen-
dicectomy with a McBurney - like (oblique) left lower
quadrant muscle-splitting incision was performed. The
patient recovered uneventfully and two days after was
exited the hospital in a fine condition.
The appendix was submitted for histopathological
examination. On gross examination accumulation of
mucus within the lumen and focal thickening of the wall
were observed. Histological examination revealed a
mucinous adenocarcinoma of the appendix (Figure 1, 2)
with the tumor to infiltrate the wall throughout the
length of the muscular layer, with no invasion whatsoever
of the subserosa and the periappendiceal fat. The muci-
nous appendiceal adenocarcinoma was classified as stage
A on Duke's staging system and as T2N0Mx according to
TNM classification. Additionally, there was no evidence
of malignancy in the appendiceal stump and the patient
was planned to a subsequent hemicolectomy.
Three months after the pathologic evaluation, the
patient underwent a subsequent extended left hemicolec-
tomy, in the pattern of the formal extended right hemi-
colectomy, with resection as well of 19 lymph nodes. On
histology, no malignancy was indentified, only three
lesions of tubular adenomas, while the lymph nodes pre-
sented plainly reactionary inflammation. No evidence of
local recurrence or metastatic disease is confirmed by the
standard follow-up, including yearly CT scanning of the
abdomen (Figure 3, 4), and the patient is fit and in good
spirit 16 months subsequent to the surgical treatment.
Conclusions
Primary mucinous adenocarcinoma of the appendix con-
stitutes a scarce malignancy of the appendix and often
associated with a second GI malignancy of the gastroin-
Figure 1 Representative areas of the mucinous adenocarcinoma 
of the appendix (H&E counterstained, magnification: × 100).
Figure 2 Histological section (H&E counterstained) of the appen-
diceal mucous adenocarcinoma (magnification: ×200).
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Page 4 of 5testinal tract. Usually the appendiceal malignancies are
mistaken for acute appendicitis and therefore their diag-
nosis follows appendectomy. Even the coexistence of pri-
mary appendiceal mucinous adenocarcinoma along with
situs inversus totalis, definitely accounts as a unique clin-
ical case, all physicians should be familiar having the
knowledge to make an appropriate and accurate diagno-
sis that will lead to prompt and correct treatment.
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Figure 3 Representative CT images of the abdomen one year af-
ter the operation during the patient's follow up. The situs inversus 
totalis is clearly demonstrated.
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